Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative sivelestat sodium in cardiac surgery for early postoperative liver and kidney function
ChiCTR2400092841Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sivelestat in cardiac disease (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Serum creatinine at 48 hours postoperatively. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
sivelestat
03
Conditions
cardiac disease
Beyond the preview
Go deeper on ChiCTR2400092841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092841.